Amphastar Pharmaceuticals (AMPH) Gross Profit Growth (3y) (2016 - 2026)
Amphastar Pharmaceuticals (AMPH) Gross Profit Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 6.23% |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 3.42% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -0.01% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 8.70% |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -3.26% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 28.48% |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 8.60% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 945.98 Mn | 655.86 Mn | 93.47 Mn | 8.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.72% |
| Mar 31, 2026 | -1.61% |
| Dec 31, 2025 | 6.38% |
| Sep 30, 2025 | 19.02% |
| Jun 30, 2025 | 10.93% |
| Mar 31, 2025 | 15.16% |
| Dec 31, 2024 | 15.50% |
| Sep 30, 2024 | 25.82% |
| Jun 30, 2024 | 26.18% |
| Mar 31, 2024 | 26.09% |
| Dec 31, 2023 | 37.69% |
| Sep 30, 2023 | 43.73% |
| Jun 30, 2023 | 29.91% |
| Mar 31, 2023 | 26.10% |
| Dec 31, 2022 | 28.70% |
| Sep 30, 2022 | 18.40% |
| Jun 30, 2022 | 25.07% |
| Mar 31, 2022 | 21.79% |
| Dec 31, 2021 | 17.47% |
| Sep 30, 2021 | 20.49% |